Allarity Therapeutics, Inc.
ALLRHealthcare|Biotechnology|US
$0.96
-0.01 (-1.13%)
DCF Value
$1.18
Tangible Book / Share
$0.22
Cash / Share
$1.07
Ownership Breakdown
76.3%
Float
15.9M
Shares Outstanding
12.1M
Float Shares
Insider Trades (60)
Last 4 quarters: 803,648 acquired · 54,107 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Graff Jeremy R. | See Remarks | Sep 30, 2026 | OPTION EX. | 39,494 | — | — | Form 4 |
| Graff Jeremy R. | See Remarks | Jan 22, 2026 | OPTION EX. | 48,147 | — | — | Form 4 |
| Graff Jeremy R. | See Remarks | Sep 30, 2026 | OPTION EX. | 39,494 | — | — | Form 4 |
| Graff Jeremy R. | See Remarks | Sep 30, 2026 | TAX W/H | 14,613 | $0.97 | $14.2K | Form 4 |
| Graff Jeremy R. | See Remarks | Jan 22, 2026 | OPTION EX. | 48,147 | — | — | Form 4 |
| Graff Jeremy R. | See Remarks | Jan 22, 2026 | TAX W/H | 17,814 | $1.18 | $21.0K | Form 4 |
| Jensen Thomas | CEO | Jan 28, 2026 | AWARD | 200,000 | — | — | Form 4 |
| Hoeiland Jesper | director | Jan 7, 2026 | AWARD | 25,000 | — | — | Form 4 |
| Hoeiland Jesper | director: | Jun 10, 2025 | OTHER | 0 | — | — | Form 4 |
| McLaughlin Gerald W. | director | Jan 28, 2026 | AWARD | 45,000 | — | — | Form 4 |
| Graff Jeremy R. | See Remarks | Jan 28, 2026 | AWARD | 133,333 | — | — | Form 4 |
| Ervin Jeffrey S | CFO | Jan 28, 2026 | AWARD | 150,000 | — | — | Form 4 |
| Graff Jeremy R. | See Remarks | Jan 7, 2026 | AWARD | 133,333 | — | — | Form 4 |
| Graff Jeremy R. | See Remarks | Sep 30, 2025 | OPTION EX. | 39,494 | — | — | Form 4 |
| Graff Jeremy R. | See Remarks | Sep 30, 2025 | OPTION EX. | 39,494 | — | — | Form 4 |
| Graff Jeremy R. | See Remarks | Sep 30, 2025 | TAX W/H | 14,613 | $1.58 | $23.1K | Form 4 |
| Ervin Jeffrey S | officer | Jul 1, 2025 | OTHER | 0 | — | — | Form 4 |
| Graff Jeremy R. | CDO | Jan 22, 2025 | AWARD | 144,441 | — | — | Form 4 |
| Epshinsky Alexander | CFO | Jan 22, 2025 | AWARD | 29,496 | — | — | Form 4 |
| Jensen Thomas | CEO | Jan 22, 2025 | AWARD | 396,734 | — | — | Form 4 |
| McLaughlin Gerald W. | director | Jan 22, 2025 | AWARD | 25,000 | $1.01 | $25.3K | Form 4 |
| Vazzano Joseph Walter | director | Jan 22, 2025 | AWARD | 25,000 | $1.01 | $25.3K | Form 4 |
| Benjamin Laura | director | Jan 22, 2025 | AWARD | 25,000 | $1.01 | $25.3K | Form 4 |
| Graff Jeremy R. | See Remarks | Sep 30, 2024 | AWARD | 118,483 | $2.11 | $250.0K | Form 4 |
| Graff Jeremy R. | officer | Sep 30, 2024 | OTHER | 0 | — | — | Form 4 |
| Epshinsky Alexander | Chief Financial Officer | Sep 12, 2024 | DISPOSED | 0 | — | — | Form 4 |
| Benjamin Laura | director: | Aug 1, 2023 | OTHER | 0 | — | — | Form 4 |
| Vazzano Joseph Walter | director: | Aug 1, 2023 | OTHER | 0 | — | — | Form 4 |
| Knudsen Jens Erik | officer | Jun 27, 2022 | OTHER | 0 | — | — | Form 4 |
| Roth David | director | Jul 7, 2022 | OTHER | 23,000 | $1.28 | $29.4K | Form 4 |
| Brown Joan Yvonne | officer | Jun 29, 2022 | OTHER | 0 | — | — | Form 4 |
| Jensen Thomas | SVP, Information Technology | Dec 20, 2021 | OTHER | 0 | — | — | Form 4 |
| Jensen Thomas | SVP, Information Technology | Dec 20, 2021 | OTHER | 161,516 | $5.16 | $833.4K | Form 4 |
| Sass Leon | 10 percent owner | Dec 20, 2021 | OTHER | 0 | — | — | Form 4 |
| Sass Leon | 10 percent owner | Dec 20, 2021 | OTHER | 0 | — | — | Form 4 |
| Knudsen Steen | Chief Scientific Officer | Dec 20, 2021 | OTHER | 0 | — | — | Form 4 |
| Knudsen Steen | Chief Scientific Officer | Dec 20, 2021 | OTHER | 0 | — | — | Form 4 |
| Knudsen Steen | Chief Scientific Officer | Dec 20, 2021 | OTHER | 78,335 | $5.16 | $404.2K | Form 4 |
| Carchedi Steve | director, officer: Chief Executive Officer | Dec 20, 2021 | OTHER | 252,555 | $5.16 | $1.3M | Form 4 |
| Carchedi Steve | director, officer: Chief Executive Officer | Dec 20, 2021 | DISPOSED | 252,555 | $5.16 | $1.3M | Form 4 |
| Carchedi Steve | director, officer: Chief Executive Officer | Dec 20, 2021 | DISPOSED | 156,025 | $8.70 | $1.4M | Form 4 |
| Carchedi Steve | director, officer: Chief Executive Officer | Dec 20, 2021 | DISPOSED | 70,477 | $12.02 | $847.1K | Form 4 |
| Carchedi Steve | director, officer: Chief Executive Officer | Dec 20, 2021 | OTHER | 70,477 | $12.02 | $847.1K | Form 4 |
| Carchedi Steve | director, officer: Chief Executive Officer | Dec 20, 2021 | OTHER | 156,025 | $8.70 | $1.4M | Form 4 |
| Jensen Soren Gade | director | Dec 20, 2021 | OTHER | 0 | — | — | Form 4 |
| Jensen Soren Gade | director | Dec 20, 2021 | OTHER | 25,842 | $10.11 | $261.3K | Form 4 |
| Jensen Soren Gade | director | Dec 20, 2021 | OTHER | 400 | $8.69 | $3.5K | Form 4 |
| Foegh Marie | Chief Medical Officer | Dec 20, 2021 | OTHER | 0 | — | — | Form 4 |
| Foegh Marie | Chief Medical Officer | Dec 20, 2021 | OTHER | 78,335 | $5.16 | $404.2K | Form 4 |
| Knudsen Jens Erik | Chief Financial Officer | Dec 20, 2021 | OTHER | 39,600 | $7.70 | $304.9K | Form 4 |
| Knudsen Jens Erik | Chief Financial Officer | Dec 20, 2021 | OTHER | 22,583 | $5.16 | $116.5K | Form 4 |
| Knudsen Jens Erik | Chief Financial Officer | Dec 20, 2021 | OTHER | 18,574 | $10.50 | $195.0K | Form 4 |
| Cullem James G. | SVP, Chief Business Officer | Dec 20, 2021 | OTHER | 28,191 | $13.22 | $372.7K | Form 4 |
| Cullem James G. | SVP, Chief Business Officer | Dec 20, 2021 | OTHER | 133,325 | $5.16 | $688.0K | Form 4 |
| Maderis Gail J | director | Dec 20, 2021 | DISPOSED | 400 | $8.69 | $3.5K | Form 4 |
| Maderis Gail J | director | Dec 20, 2021 | DISPOSED | 25,842 | $10.11 | $261.3K | Form 4 |
| Maderis Gail J | director | Dec 20, 2021 | OTHER | 400 | $8.69 | $3.5K | Form 4 |
| Maderis Gail J | director | Dec 20, 2021 | OTHER | 25,842 | $10.11 | $261.3K | Form 4 |
| Moore Duncan | director | Dec 20, 2021 | OTHER | 0 | — | — | Form 4 |
| Moore Duncan | director | Dec 20, 2021 | OTHER | 41,994 | $10.11 | $424.6K | Form 4 |